CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer

References

• ChenWZhengRZengHZhangSThe incidence and mortality of major cancers in China, 2012Chin J Cancer20163517327484217
   PubMedGoogle Scholar
• UngMRouquetteIFilleronTCharacteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the LungClin Lung Cancer201617539139727105684
   PubMed Web of Science ®Google Scholar
• PelosiGSonzogniAde PasTReview article: pulmonary sarcomatoid carcinomas: a practical overviewInt J Surg Pathol201018210312019124452
   PubMed Web of Science ®Google Scholar
• MartinLWCorreaAMOrdonezNGSarcomatoid carcinoma of the lung: a predictor of poor prognosisAnn Thorac Surg200784397398017720411
   PubMed Web of Science ®Google Scholar
• SteuerCEBeheraMLiuYPulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data BaseClin Lung Cancer201718328629228043773
   PubMed Web of Science ®Google Scholar
• VieiraTGirardNUngMEfficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinomaJ Thorac Oncol20138121574157724389441
   PubMed Web of Science ®Google Scholar
• YvorelVPatoirACasteilloFPD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosisPLoS One2017127e018034628671973
   PubMed Web of Science ®Google Scholar
• ChangYLYangCYLinMWWuCTYangPCHigh co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinomaEur J Cancer20166012513527107327
   PubMed Web of Science ®Google Scholar
• JiangXLiuYChenCThe value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 casesClin Lung Cancer201213428829622169481
   PubMed Web of Science ®Google Scholar
• VerdegaalEMHoogstratenCSandelMHFunctional CD8+ T cells infiltrate into nonsmall cell lung carcinomaCancer Immunol Immunother200756558760016924494
   PubMed Web of Science ®Google Scholar
• UsóMJantus-LewintreEBremnesRMAnalysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markersOncotarget2016733528495286127463005
   PubMedGoogle Scholar
• StantonSEDisisMLClinical significance of tumor-infiltrating lymphocytes in breast cancerJ Immunother Cancer201645927777769
   PubMed Web of Science ®Google Scholar
• TamadaKShimozakiKChapovalAIModulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathwayNat Med20006328328910700230
   PubMed Web of Science ®Google Scholar
• CaoXRegulatory T cells and immune tolerance to tumorsImmunol Res2010461–3799319763889
   PubMed Web of Science ®Google Scholar
• MahmoudSMPaishECPoweDGTumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancerJ Clin Oncol201129151949195521483002
   PubMed Web of Science ®Google Scholar
• KawaiOIshiiGKubotaKPredominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancerCancer200811361387139518671239
   PubMed Web of Science ®Google Scholar
• GalonJCostesASanchez-CaboFType, density, and location of immune cells within human colorectal tumors predict clinical outcomeScience200631357951960196417008531
   PubMed Web of Science ®Google Scholar
• FangJLiXMaDPrognostic significance of tumor infiltrating immune cells in oral squamous cell carcinomaBMC Cancer201717137528549420
   PubMed Web of Science ®Google Scholar
• GiuşcăSEWierzbickiPMAmălineiCCăruntuIDAvădăneiERComparative analysis of CD4 and CD8 lymphocytes - evidences for different distribution in primary and secondary liver tumorsFolia Histochem Cytobiol201553327228126484587
   PubMed Web of Science ®Google Scholar
• WangQLouWdiWWuXPrognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancerInt Immunopharmacol20175271428846888
   PubMed Web of Science ®Google Scholar
• TengFMengXWangXExpressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisionsOncotarget2016739643186432927602763
   PubMedGoogle Scholar
• TokitoTAzumaKKawaharaAPredictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapyEur J Cancer20165571426771872
   PubMed Web of Science ®Google Scholar
• PrendergastGCJaffeeEMCancer immunologists and cancer biologists: why we didn’t talk then but need to nowCancer Res20076783500350417413003
   PubMed Web of Science ®Google Scholar
• JackuteJZemaitisMPranysDThe prognostic influence of tumor infiltrating Foxp3(+)CD4(+), CD4(+) and CD8(+) T cells in resected non-small cell lung cancerJ Inflamm20151263
   Google Scholar
• BremnesRMDonnemTBusundLTImportance of tumor infiltrating lymphocytes in non-small cell lung cancer?Ann Transl Med20164714227162792
   PubMed Web of Science ®Google Scholar
• Al-ShibliKIDonnemTAl-SaadSPerssonMBremnesRMBusundLTPrognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancerClin Cancer Res200814165220522718698040
   PubMed Web of Science ®Google Scholar
• MiyashitaMSasanoHTamakiKPrognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter studyBreast Cancer Res20151712426341640
   PubMed Web of Science ®Google Scholar
• TurcotteSGrosATranETumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapyClin Cancer Res201420233134324218514
   PubMed Web of Science ®Google Scholar
• MichelFAttal-BonnefoyGManginoGMise-OmataSAcutoOCD28 as a molecular amplifier extending TCR ligation and signaling capabilitiesImmunity200115693594511754815
   PubMed Web of Science ®Google Scholar
• BlokEJvan den BulkJDekker-EnsinkNGCombined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancerOncotarget201789156101562028121628
   PubMedGoogle Scholar
• BertrandFRochotteJColaciosCTargeting TNF alpha as a novel strategy to enhance CD8+ T cell-dependent immune response in melanoma?Oncoimmunology201651e106849526942089
   PubMed Web of Science ®Google Scholar
• ShaoSRischEBurnerDLuLMinevBMaWIFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cellsInt Immunopharmacol20174715916528410529
   PubMed Web of Science ®Google Scholar
• SchalperKABrownJCarvajal-HausdorfDObjective measurement and clinical significance of TILs in non-small cell lung cancerJ Natl Cancer Inst20151073
   Google Scholar